Please login to the form below

Not currently logged in
Email:
Password:

Variety in spending across NHS

Spending per head on health and social care varied by almost £400 across the four UK countries in the financial year 2006-07
Spending per head on health and social care varied by almost £400 across the four UK countries in the financial year 2006-07.

Total expenditure per head was lowest in England at £1,915 and greatest in Scotland at £2,313. Expenditure for Wales and Northern Ireland were £2,109 and £2,096, respectively.

These figures form part of the United Kingdom Health Statistics report published by the Office for National Statistics (ONS).

The report also shows that in 2005, England had the highest life expectancy at birth with 77.2 years for men and 81.5 years for women, whereas Scotland had the lowest with 74.6 years for men and 79.6 years for women. Compared internationally, the UK as a whole was slightly above the EU average for male life expectancy and slightly below for female.

Other key finding show:

Between 1995 and 2005 there was an increase in the number of women who started breastfeeding across all four countries of the UK. The highest rate of breastfeeding (77 per cent) was in England and Wales. However, the proportion of mothers who breastfed in 2005 compared with 1995, increased by 18 per cent in Northern Ireland. This was higher than Scotland (15 per cent) and England and Wales (9 per cent).

Deaths relating to drug poisoning were highest in Scotland for both males at 17 deaths per 100,000 population, and females at six per 100,000 in 2006. Northern Ireland had the lowest rate for males at six deaths per 100,000 and England had the lowest rate for females at three deaths per 100,000.

10th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics